Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chenyl Taurine Sodium
2. Tauroursodeoxycholate
3. Tauroursodeoxycholate Sodium Salt
4. Tauroursodeoxycholic Acid
5. Tauroursodeoxycholic Acid, (3alpha,5alpha,7alpha)-isomer
6. Tauroursodeoxycholic Acid, Monosodium Salt, (3alpha,5beta,7alpha)-isomer
7. Taurursodiol
8. Tudca
9. Ursodoxicoltaurine
1. 35807-85-3
2. Ursodeoxycholyltaurine Sodium
3. Tauroursodeoxycholic Acid Sodium Salt
4. Sodium Tauroursodeoxycholate (tudc)
5. Tauroursodeoxycholate Sodium
6. Sodium Tauroursodesoxycholate
7. Tauroursodeoxycholate (sodium)
8. Tauroursodeoxycholate Sodium Salt
9. 6x4jlr867n
10. Sodium Taurochenodesoxycholate
11. Taurochenodeoxycholic Acid Sodium Salt
12. Tudca Sodium
13. Tauroursodeoxycholic Acid Sodium Salt (90%)
14. P2sd3phq3y
15. Chenyl Taurine Sodium
16. Unii-6x4jlr867n
17. Tudc
18. Nsc 681055
19. Unii-p2sd3phq3y
20. Tauroursodeoxycholatesodium
21. Taurursodiol Sodium
22. Ursodoxicoltaurine Sodium
23. Schembl10695686
24. Tauroursodeoxycholic Acidsodium Salt
25. Sodium;2-[[(4r)-4-[(3r,5s,7s,8r,9s,10s,13r,14s,17r)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate
26. Hy-19696a
27. S7896
28. Akos016005356
29. Ccg-269868
30. Cs-5351
31. 2-(((3alpha,5beta,7alpha)-3,7-dihydroxy-24-oxocholan-24-yl)amino)ethanesulfonic Acid Monosodium Salt
32. Ethanesulfonic Acid, 2-(((3alpha,5beta,7alpha)-3,7-dihydroxy-24-oxocholan-24-yl)amino)-, Monosodium Salt
33. Ethanesulfonic Acid, 2-(((3alpha,5beta,7beta)-3,7-dihydroxy-24-oxocholan-24-yl)amino)-, Sodium Salt (1:1)
34. Ursodoxicoltaurine Sodium [who-dd]
35. C74842
36. Q27265654
37. 3a,7ss-dihydroxy-5ss-cholan-24-oic Acid N-(2-sulfoethyl)amide
38. Ethanesulfonic Acid, 2-(((3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl)amino)-, Monosodium Salt
39. Ethanesulfonic Acid, 2-(((3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl)amino)-, Sodium Salt (1:1)
Molecular Weight | 521.7 g/mol |
---|---|
Molecular Formula | C26H44NNaO6S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 521.27870358 g/mol |
Monoisotopic Mass | 521.27870358 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 864 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Cholagogues and Choleretics
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)
ABOUT THIS PAGE
A Sodium Tauroursodeoxycholate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Tauroursodeoxycholate, including repackagers and relabelers. The FDA regulates Sodium Tauroursodeoxycholate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Tauroursodeoxycholate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Tauroursodeoxycholate supplier is an individual or a company that provides Sodium Tauroursodeoxycholate active pharmaceutical ingredient (API) or Sodium Tauroursodeoxycholate finished formulations upon request. The Sodium Tauroursodeoxycholate suppliers may include Sodium Tauroursodeoxycholate API manufacturers, exporters, distributors and traders.
Sodium Tauroursodeoxycholate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Tauroursodeoxycholate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Tauroursodeoxycholate GMP manufacturer or Sodium Tauroursodeoxycholate GMP API supplier for your needs.
A Sodium Tauroursodeoxycholate CoA (Certificate of Analysis) is a formal document that attests to Sodium Tauroursodeoxycholate's compliance with Sodium Tauroursodeoxycholate specifications and serves as a tool for batch-level quality control.
Sodium Tauroursodeoxycholate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Tauroursodeoxycholate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Tauroursodeoxycholate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Tauroursodeoxycholate EP), Sodium Tauroursodeoxycholate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Tauroursodeoxycholate USP).
LOOKING FOR A SUPPLIER?